8:30

Continental Breakfast

9:00

Welcome and Opening Remarks

Adel Mahmoud, President, Merck Vaccines Chair

Forum on Emerging Infections

9:15

The World and Its Moving Parts

Martin Cetron, Deputy Director, Division of Quarantine,

National Center for Infectious Diseases, CDC

9:35

Global Migration and Infectious Diseases

Danielle Grondin, Director, Migration Health Services,

International Organization of Migration

9:55

Globalization of the Food Supply

David Acheson, Chief Medical Officer, Food Safety and Inspection Service, USDA

10:15

Changing Vector Ecologies: Political Geographic Perspectives

Jonathan Mayer, Professor, Geography, College of Arts and Sciences, University of Washington, Seattle

10:35

BREAK

10:50

Invited Discussion: A Response to the Shifting Trends

Moderator: Margaret Hamburg, Vice-President, Biologicals Program, Nuclear Threat Initiative

Stephen Corber, Director, Division of Disease Prevention and Control, Pan American Health Organization

Mary Wilson, Professor of Medicine, Harvard Medical School, Population and International Health

Judith Miller, Journalist, the New York Times

David Heyman, Senior Fellow, Center for Strategic and International Studies

12:30

Lunch

1:30

The Global Infectious Disease Threat

David Gordon, Intelligence Officer, Economics and Global Health Issues, National Intelligence Council

1:50

Health, Human Rights, and Humanitarian Assistance: The Medical and Public Health Response to Crises and Disasters Jennifer Leaning, Professor, Population and International Health, Harvard University

2:10

Social Aspects of Public Health Challenges in a Period of Globalization: The Case of Russia

Andrey Demin, President, Russian Public Health Association and Professor, I.M. Sechenov Medical Academy, Moscow

2:30

Considerations for Drug Access and Delivery in the Developing World

Robert Redfield, Professor and Associate Director, Institute of Human Virology, University of Maryland, Baltimore

2:50

Impediments to Global Surveillance and Open Reporting of Infectious Diseases

Richard Cash, Lecturer on International Health, Harvard School of Public Health

3:10

International Law, Infectious Disease, and Globalization

David Fidler, Professor of Law and Ira C. Batman Faculty Fellow, School of Law, Indiana University

3:30

BREAK

3:45

Invited Discussion: Considering the Resources and Capacity for the Response

Moderator: Stanley Lemon, Dean of Medicine, University of Texas, Medical Branch, Galveston

Farley Cleghorn, Senior Scientist, Institute of Human Virology, University of Maryland, Baltimore

Ann Marie Kimball, Professor, Epidemiology and Health Services, University of Washington, Seattle

Michele Barry, President, American Society of Tropical Medicine and Hygiene, Professor, Yale University, School of Medicine

Jonathan Patz, Associate Professor, Bloomberg School of Public Health, Johns Hopkins University

5:30

Adjournment of the first day

5:45

Reception, Members Room of the NAS

6:15

Dinner Meeting for Forum Members

8:30

Continental Breakfast

9:00

Opening Remarks/Day One Summary Stanley Lemon

Vice-Chair, Forum on Emerging Infections

9:15

Globalization and Health: A Framework for Analysis and Action

Douglas Klaucke, Communicable Disease Surveillance and Response, World Health Organization

9:35

New Directions in Capacity Building

Pierce Gardner, Senior Advisor for Clinical Research and Training, Fogarty International Center, NIH

9:55

Partnering for Success: The Role of Private-Public Sector Collaboration

Roy Widdus, Project Manager, Initiative for Public-Private Partnerships for Health, Geneva

10:15

The Current Situation and Perspectives of International Collaboration in the Field of Biomedical Sciences: The Example of the State Research Center of Virology and Biotechnology (VECTOR)

Sergei Netesov, Deputy Director, VECTOR Laboratories, Koltsovo, Russia

10:35

Protecting the Nation’s Health in an Era of Globalization, CDC’s Global Infectious Disease Strategy

Eric Mintz, Acting Associate Director for Global Health, CDC

10:55

The Global Fund: A Brave New World

William Steiger, Special Assistant to the Secretary, International Affairs, Department of Health and Human Services

11:15

BREAK

11:30

Invited Discussion: Considerations for Shaping the Agenda

Olusoj Adeyi, Senior Health Specialist, World Bank

William Makgoba, President, Medical Research Council of South Africa (by teleconference)

Mark Miller, Associate Director for Research and Director, Division of International Epidemiology and Population Studies, Fogarty International Center, NIH

Ralph Timperi, Chair, APHL Global Health Committee and Assistant Commissioner/Director, State Laboratory Institute Massachusetts Department of Public Health

1:00

Lunch

2:00

With the backdrop of the two days’ presentations and discussion, Forum members, panel discussants, and the audience will comment on the issues and next steps that they would identify as priority areas for consideration within industry, academia, government agencies, public health organizations, and other nongovernmental organizations. The discussion of priorities will summarize the issues surrounding emerging opportunities for more effective collaboration as well as the options and considerations for research, development, and capacity building. The complexities of interactionamong private industry, research and public health agencies, regulatory agencies, policymakers, academic researchers, and the public will be explored with an eye toward innovative responses to the challenges and opportunities presented by an increasingly “globalized” world.

Invited Panel Discussants:

Eduardo Gotuzzo, President, Latin American Society of Tropical Medicine and Principal Professor, University Perudad Cayetano Heredia, Peru

Reinhard Kurth, President, the Robert Koch Institute, Berlin

Jim LeDuc, Acting Director, Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention

3:30

Roundtable Discussion

4:30

Closing Remarks / Adjournment

Adel Mahmoud, President, Merck Vaccines Chair, Forum on Emerging Infections